Acquisition by Jerel Davis of 20000 shares of Graphite Bio subject to Rule 16b-3
| GRPHDelisted Stock | USD 2.67 0.05 1.84% |
Under 61% of Graphite Bio's investor base is looking to short. The analysis of current outlook of investing in Graphite Bio suggests that many traders are alarmed regarding Graphite Bio's prospects. Graphite Bio's investing sentiment shows overall attitude of investors towards Graphite Bio.
Graphite |
Filed transaction by Graphite Bio Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Graphite Bio Fundamental Analysis
We analyze Graphite Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Graphite Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Graphite Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Graphite Bio is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Graphite Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Graphite Bio stock to make a market-neutral strategy. Peer analysis of Graphite Bio could also be used in its relative valuation, which is a method of valuing Graphite Bio by comparing valuation metrics with similar companies.
Peers
Graphite Bio Related Equities
| TIL | Instil Bio | 2.52 | ||||
| SNSE | Sensei Biotherapeutics | 2.33 | ||||
| ASMB | Assembly Biosciences | 0.20 | ||||
| ACHL | Achilles Therapeutics | 0.01 | ||||
| NUVB | Nuvation Bio | 0.76 | ||||
| CTMX | CytomX Therapeutics | 0.89 | ||||
| NXTC | NextCure | 0.92 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Graphite Stock
If you are still planning to invest in Graphite Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Graphite Bio's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |